Posted in | News | MEMS - NEMS | Nanobusiness

Teledyne Technologies Signs Definitive Agreement to Buy DALSA

Teledyne Technologies Incorporated ("Teledyne") (NYSE: TDY) and DALSA Corporation ("DALSA") (TSX: DSA) jointly announced today that they have entered into a definitive agreement that provides for the acquisition of DALSA Corporation by a wholly-owned subsidiary of Teledyne.

Pursuant to the transaction, Teledyne will acquire all of the outstanding common shares of DALSA for CAD $18.25 per share payable in cash. The aggregate value for the transaction is approximately CAD $341 million, taking into account DALSA's stock options and net cash as of September 30, 2010.

"Teledyne and DALSA are each acknowledged leaders in digital imaging technology but our product lines and customer bases are almost entirely complementary. For example, DALSA produces among the world's most advanced visible light imaging sensors and cameras for commercial applications, while Teledyne produces extreme resolution infrared sensors and subsystems primarily for government applications," said Dr. Robert Mehrabian, Chairman, President and Chief Executive Officer of Teledyne. "The combined strengths of Teledyne's and DALSA's leading imaging technologies will allow us to develop new infrared and visible light products that serve our respective markets and customers. Furthermore, DALSA's custom MEMS capabilities will be augmented by having access to Teledyne's extensive MEMS research activities and advanced process technologies.

"With the acquisition of DALSA, Teledyne is making a substantial commitment to Canada. We are especially attracted to strong support for research and development and advancement of technology provided by both the Canadian Federal and Provincial Governments of Ontario and Quebec. Finally, following the acquisition of DALSA, and the previously announced divestiture of Teledyne Continental Motors, Teledyne will be transformed into a pure-play electronics, instrumentation and engineering focused company."

"I view this transaction as a natural evolution for DALSA and a positive development for all DALSA stakeholders including shareholders, employees, executives, local communities, customers and vendors," commented Dr. Savvas Chamberlain, Chairman of the Board and Founder of DALSA. "The decision to be a part of a larger organization recognizes that in order for DALSA to become a billion dollar company, we need to team up with an industry leader with complementary technologies. Finally, as the founder of the company, I am pleased to see DALSA's name live on, in its new incarnation as Teledyne DALSA."

"Being part of the Teledyne team will provide many opportunities for accelerated growth for DALSA," said Brian Doody, Chief Executive Officer of DALSA. "I am looking forward to working with my existing management and executive team, along with the Teledyne team, as we move forward together in the next stage of the company's development. As envisioned in the agreement with Teledyne, our principal operations will continue to function in their existing locations. Moreover, Teledyne expects to continue to invest in our technology and business."

Source: http://www.dalsa.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Teledyne DALSA. (2019, February 13). Teledyne Technologies Signs Definitive Agreement to Buy DALSA. AZoNano. Retrieved on May 25, 2024 from https://www.azonano.com/news.aspx?newsID=21072.

  • MLA

    Teledyne DALSA. "Teledyne Technologies Signs Definitive Agreement to Buy DALSA". AZoNano. 25 May 2024. <https://www.azonano.com/news.aspx?newsID=21072>.

  • Chicago

    Teledyne DALSA. "Teledyne Technologies Signs Definitive Agreement to Buy DALSA". AZoNano. https://www.azonano.com/news.aspx?newsID=21072. (accessed May 25, 2024).

  • Harvard

    Teledyne DALSA. 2019. Teledyne Technologies Signs Definitive Agreement to Buy DALSA. AZoNano, viewed 25 May 2024, https://www.azonano.com/news.aspx?newsID=21072.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.